GenoFocus Acquires Patent for the Oral Plaque-Fighting Enzyme Mutanase

GenoFocus is pleased to announce that we have acquired a patent for mutanase, an oral care enzyme designed to combat plaque. GF Mutanase is alpha 1,3-glucanase which has a specific oral plaque binding domain. Therefore, it can maintain its catalytic activity even after users rinse their mouths.

GenoFocus plans to promote GF Mutanase to the global market this year.